微信直播

Ashish M Kamat教授:良好协作造就优秀的手术团队

Published at: 2015年第1卷第S1期

AME
关键词:

编者按:中国抗癌协会泌尿男生殖系统肿瘤专委会2017年会暨第七届上海泌尿肿瘤国际论坛于2017年12月9日-10日圆满召开。本次大会由中国抗癌协会泌尿男生殖系统肿瘤专业委员会、上海市抗癌协会联合主办,复旦大学附属肿瘤医院承办。会议不仅邀请了国内众多顶尖泌尿外科专家,还特别邀请了来自国际知名肿瘤中心的国际专家与会,并且特设诸多亮点专场,安排共识发布和新书Urinary System Tumor发布等环节,为大家精心呈现了一场泌尿男生殖系统肿瘤领域的年度盛事与学术盛宴。在会议中,编者采访了来自美国MD Anderson癌症中心的Ashish M Kamat教授(图1)。

图1. Kamat教授与AME科学编辑合影

人物聚焦:Ashish M Kamat

Dr Ashish M. Kamat is a Professor (Tenure) of Urology and Director of Urologic Oncology Fellowship at M.D. Anderson Cancer Center, and a graduate of the AUA Leadership Program.

Dr Kamat’s expertise is in multidisciplinary management of urologic cancers with an emphasis bladder and prostate cancer, organ sparing therapies, minimally invasive techniques, and orthotopic bladder substitution (neobladder). While he is a busy surgeon, he maintains an active research portfolio to improve the care of patients. Dr Kamat’s efforts are directed towards identifying predictors of response to therapy - especially immunotherapy - as a first step towards personalized cancer therapeutics. A major focus of his laboratory research is to develop novel treatments for bladder cancer and identify resistance mechanisms and ways to overcome them. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE.

Dr Kamat has authored over 200 publications, editorials & book chapters in prestigious journals; he is listed in'Who's Who in Medicine' and ‘Best Doctors in America’ and has won the Compassionate Doctor Award from patient groups. He is an exceptional educator nominated twice for the Robert M. Chamberlain Distinguished Mentor Award and has been invited as a visiting professor to several universities across the world.

Dr Kamat is Co President, International Bladder Cancer Network, Chair, Bladder Cancer Think Tank (2015), Chair, Bladder Cancer Task Force for SITC, actively participates in various global urologic efforts, and serves on the board of regional and national societies for Urology.

Ashish M. Kamat教授是国际膀胱癌研究组(IBCG)主席和国际膀胱癌协作组共同主席(2015),AUA膀胱癌指南委员会成员和AUA德克萨斯州主任委员。他致力于在全球推广膀胱癌手术治疗、尿流改道技术和微创治疗。膀胱癌根治术是一项复杂的手术,但该手术是治疗膀胱癌的重要手段之一。Kamat教授说,许多研究表明,膀胱癌患者的治疗效果与医院实施根治性膀胱切除术的手术量呈正相关的关系,手术量大的医院的患者拥有更好的治疗效果。Kamat教授任职的MD Anderson癌症中心每年实施近300例根治性膀胱切除术。相对于手术量低的医院,该中心的患者治疗效果更佳,处于美国领先地位。Kamat教授说,根治性膀胱切除术常见的术后并发症包括伤口感染,延迟愈合等。随着外科医生对根治性膀胱切除术的熟悉与掌握,一些致命且严重的并发症较以往少见了。

Kamat教授在本次会议中分享了膀胱癌根治术及术后加速康复的经验。在采访中,他提到,泌尿外科的加速康复是由胃肠外科加速康复理念引进来的,还在发展当中。为成功实现患者的加速康复,医生、患者及患者家属需要一起努力。比如,在术前,医生需要对患者和患者家属进行培训,让他们了解加速康复及照顾患者的适当做法。不同于传统的术前准备,患者不需要在术前进行胃肠道准备。手术后,患者也可早些进食。Kamat教授最后提到,泌尿外科手术和其他外科手术一样,讲究团队协作。外科医生虽说是手术中的指挥者,但手术结果的好坏依靠的是整个团队的合作。团队协作得好,就能造就一支优秀的手术团队。

欲知更多精彩内容,欢迎观看下方采访视频。

采访问题

1. Could you share with us the experience of radical cystectomy in your center“MD Anderson Cancer Center”?

2. What are the most common complications of the radical cystectomy?

3. In your opinion, what are the key points for successful ERAS in radical cystectomy?

4. In your center, what is the percentage of patients undergoing ERAS after radical cystectomy? What is the percentage in USA? Is the concept “ERAS” still new to the patients?

5. With the development of minimally invasive techniques, traditional open surgeries gradually decreased. Meanwhile, young doctors might have less opportunity for learning the anatomic structure in surgeries. Do you have any suggestions for young doctors who want to improve their surgical techniques?

6. You were a graduate of the AUA Leadership Program. What have you learned from AUA Leadership Program?

7. What do you think makes a great team of urological surgeons based on your experience?

8. Surgeons are always busy. How do you balance your work and family life? 


采访编辑:徐文珂,AME Publishing Company

撰写编辑:刘燕华,AME Publishing Company

视频编辑:麦雪芳,AME Publishing Company

排版编辑:许梦杨,AME Publishing Company

学术审核:李潇,江苏省肿瘤医院

comments powered by Disqus

附件